Arnar Geirsson
banner
arnargeirssonmd.bsky.social
Arnar Geirsson
@arnargeirssonmd.bsky.social
Professor of Surgery at NewYork Presbyterian Columbia University Medical Center. Specializes in valve surgery and robotic mitral valve repair
Reposted by Arnar Geirsson
Mitral valve prolapse currently has no medical therapy to slow its progression.

@arnargeirssonmd.bsky.social now identify altered mTOR signaling in a mouse model of severe myxomatous mitral valve degeneration— with rapamycin rescuing the mitral phenotype: buff.ly/lkbNEBB
July 28, 2025 at 3:33 PM
Always a pleasure contributing to understanding pathogenesis of MVP
JCI - Integrin-mediated mTOR signaling drives TGF-β overactivity and myxomatous mitral valve degeneration in hypomorphic fibrillin-1 mice www.jci.org/articles/vie...
JCI - Integrin-mediated mTOR signaling drives TGF-β overactivity and myxomatous mitral valve degeneration in hypomorphic fibrillin-1 mice
www.jci.org
July 16, 2025 at 6:40 PM
Setting Benchmarks for Long-Term Success of Surgical Mitral Valve Repa... www.sciencedirect.com/science/arti...
www.sciencedirect.com
February 5, 2025 at 8:01 PM